Impact of double filtration plasmapheresis on adhesion molecules levels in patients with stable coronary heart disease after coronary stenting

Stettler, 2007, Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis, Lancet, 370, 937, 10.1016/S0140-6736(07)61444-5 Dangas, 2010, In-stent restenosis in the drug-eluting stent era, J Am Coll Cardiol, 56, 1897, 10.1016/j.jacc.2010.07.028 Farb, 2002, Morphological predictors of restenosis after coronary stenting in humans, Circulation, 105, 2974, 10.1161/01.CIR.0000019071.72887.BD Smith, 2006, AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update, Circulation, 113, 2363, 10.1161/CIRCULATIONAHA.106.174516 Windecker, 2014, ESC/EACTS Guidelines on myocardial revascularization, Eur Heart J, 35, 2541 Libby, 2002, Inflammation in atherosclerosis, Nature, 420, 868, 10.1038/nature01323 Inami, 2005, Association of leukocyte activation, but not the common cold, with restenosis after percutaneous coronary intervention in patients with angina pectoris, Pathophysiol Haemost Thromb, 34, 13, 10.1159/000088542 Inoue, 2011, Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis, JACC Cardiovasc Interv, 4, 1057, 10.1016/j.jcin.2011.05.025 Welt, 2002, Inflammation and restenosis in the stent era, Arterioscler Thromb Vasc Biol, 22, 1769, 10.1161/01.ATV.0000037100.44766.5B Blann, 1995, Von Willebrand Factor, soluble P-selectin, tissue plasminogen activator inhibitor in atherosclerosis, Thromb Haemost, 74, 626, 10.1055/s-0038-1649788 Xia, 2011, Expression of P-selectin, von Willebrand and endothelin-1 after carotid artery stenting, Vasa, 40, 199, 10.1024/0301-1526/a000094 Murasaki, 2007, High P-selectin expression and low CD36 occupancy on circulating platelets are strong predictors of restenosis after coronary stenting in patients with coronary artery disease, Heart Vessels, 22, 229, 10.1007/s00380-006-0966-5 Kozinski, 2007, Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting, Int J Mol Med, 19, 187 Jang, 1994, Cell adhesion molecules in coronary artery disease, J Am Coll Cardiol, 24, 1591, 10.1016/0735-1097(94)90162-7 Witkowska, 2004, Soluble intercellular adhesion molecule-1 (sICAM-1): an overview, Eur Cytokine Netw, 15, 91 Klouche, 1999, Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers, Arterioscler Thromb Vasc Biol, 19, 784, 10.1161/01.ATV.19.3.784 Bayata, 2010, An important role for VCAM-1, but not for ICAM-1 in restenosis following coronary stent implantation, Anatol J Cardiol, 10, 405, 10.5152/akd.2010.137 Satoh, 2010, Soluble TRAIL prevents RANTES-dependent restenosis after percutaneous coronary intervention in patients with coronary artery disease, J Thromb Thrombolysis, 29, 471, 10.1007/s11239-009-0364-9 Chen, 2009, PECAM-1 is necessary for flow-induced vascular remodeling, Arterioscler Thromb Vasc Biol, 29, 1067, 10.1161/ATVBAHA.109.186692 Stefanutti, 2011, Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresis, Cytokine, 55, 245, 10.1016/j.cyto.2011.04.003 Yuasa, 2014, Proteomic analysis of proteins eliminated by low-density lipoprotein apheresis, Ther Apher Dial, 18, 93, 10.1111/1744-9987.12056 Hovland, 2012, LDL apheresis and inflammation-implications for atherosclerosis, Scand J Immunol, 76, 229, 10.1111/j.1365-3083.2012.02734.x Empen, 2002, The effects of three different LDL apheresis methods on the plasma concentrations of E-selectin, VCAM-1, and ICAM-1, J Clin Apher, 17, 38, 10.1002/jca.10010 Wang, 2004, Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins-reduction of circulating proinflammatory and procoagulatory markers, Atherosclerosis, 175, 145, 10.1016/j.atherosclerosis.2004.03.011 Moriarty, 2006, LDL-apheresis therapy, Curr Treat Options Cardiovasc Med, 8, 282, 10.1007/s11936-006-0049-z Richter, 2001, Effect of extracorporeal low-density lipoprotein elimination on circulating cell adhesion molecules in patients with hypercholesterolemia, Am J Cardiol, 87, 1111, 10.1016/S0002-9149(01)01473-4 Sampietro, 1997, Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia, Circulation, 96, 1381, 10.1161/01.CIR.96.5.1381 Utsumi, 2007, Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis, Clin Chim Acta, 377, 198, 10.1016/j.cca.2006.09.026 Yamane, 1998, Double filtration plasmapheresis maintains normal adhesion molecule levels, Ther Apher, 2, 224, 10.1111/j.1744-9987.1998.tb00108.x Hanafusa, 2011, Theoretical basis of pathogenic substance removal during plasmapheresis, Ther Apher Dial, 15, 421, 10.1111/j.1744-9987.2011.00930.x